Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis
Journal of Allergy and Clinical Immunology · 2024
DOI: 10.1016/j.jaci.2024.07.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Guillaume Lefèvre und 30 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute …. Hauptthemen laut MEDLINE: Mast Cells, Eosinophils, Mastocytosis, Systemic, Interleukin-5 Receptor alpha Subunit. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: GSK.
Abstract (Originalsprache)
BACKGROUND: Bidirectional interactions between eosinophils and mast cells (MCs) have been reported in various allergic diseases. Bone marrow (BM) eosinophilia, and to a lesser extent blood eosinophilia, is common in systemic mastocytosis (SM), but its significance remains unknown. OBJECTIVE: We described blood and BM eosinophil characteristics in SM. METHODS: A large collection of BM biopsy samples was analyzed using immunohistochemical staining and whole-slide imaging. Eosinophil and extracellular granules were detected by eosinophil peroxidase (EPX) staining and MCs by KIT staining. Complementary analyses were conducted using flow cytometry and immunofluorescence. RESULTS: Eosinophil infiltrates and large areas of eosinophil degranulation were observed within or around BM MC infiltrates in SM. EPX staining surface, highlighting intact eosinophils and eosinophil degranulation, was higher in nonadvanced SM (n = 37 BM biopsy samples) compared with both controls (n = 8, P = .0003) and advanced SM (n = 24, P = .014). In nonadvanced SM, positive correlations were observed between serum tryptase levels and percentages of eosinophil counts in BM aspirations (Spearman r coefficient r = 0.38, P = .038), eosinophils count in BM biopsy samples (r = 0.45, P = .007), EPX staining (r = 0.37, P = .035), and eosinophil degranulation (r = 0.39, P = .023). Eosinophil counts in BM biopsy samples also correlated with MC counts (r = 0.47, P = .006) and KIT staining surface (r = 0.49, P = .003). BM MCs expressed IL-5 receptor and other usual eosinophil cytokine/chemokine receptors, and blood eosinophils displayed several increased surface markers compared with controls, suggesting an activated state. CONCLUSION: Our data suggest possible cross talk between MCs and eosinophils, supporting MC tryptase release and MC activation-related symptoms. This suggests a rationale for targeting eosinophils in nonadvanced SM not fully controlled by other therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France;…
- University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.
- Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France.
- Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mas…
- University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants M…
- CEREMAST, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Unit de Dermatologie, Sorbonne Université Paris, Paris, France.
Förderung
- GSK
Zitieren
APA
Lefèvre, G., Gibier, J. B., Bongiovanni, A., Lhermitte, L., Rossignol, J., Anglo, E., Dendooven, A., Dubois, R., Terriou, L., Launay, D., Barete, S., Esnault, S., Frenzel, L., Gourguechon, C., Ballul, T., Dezoteux, F., Staumont-Salle, D., Copin, M. C., Rignault-Bricard, R., …, & Hermine, O. (2024). Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.07.025
Vancouver
Lefèvre G, Gibier JB, Bongiovanni A, Lhermitte L, Rossignol J, Anglo E, et al. Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2024.07.025
BibTeX
@article{Lefvre2024,
author = {Lefèvre, Guillaume and Gibier, Jean-Baptiste and Bongiovanni, Antonino and Lhermitte, Ludovic and Rossignol, Julien and Anglo, Emilie and Dendooven, Arnaud and Dubois, Romain and Terriou, Louis and Launay, David and Barete, Stéphane and Esnault, Stéphane and Frenzel, Laurent and Gourguechon, Clément and Ballul, Thomas and Dezoteux, Frédéric and Staumont-Salle, Delphine and Copin, Marie-Christine and Rignault-Bricard, Rachel and Maciel, Thiago Trovati and Damaj, Gandhi and Tardivel, Meryem and Crinquette-Verhasselt, Marie and Dubreuil, Patrice and Maouche-Chrétien, Leila and Bruneau, Julie and Lortholary, Olivier and Duployez, Nicolas and Behal, Hélène and Molina, Thierry Jo and Hermine, Olivier},
title = {Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
doi = {10.1016/j.jaci.2024.07.025}
}
EUVIMED